medicines

If you have become aware of information regarding the safety of Avexima's medicinal product, please fill out the notification form provided on the website or inform us by e-mail:

PHARMAKONADZOR@AVEXIMA.RU

or by phone:

+7 495 258 45 28

Please note that all information provided in this form will be used confidentially and exclusively for pharmacovigilance purposes to ensure drug safety.
A specialist from the pharmacovigilance department will contact you if necessary.

Avexima provides scientific and medical information about the company's medicines in response to requests from healthcare professionals and consumers (patients, relatives of patients, etc.).

Upon request, consumers are provided with information within the framework of the instructions for the medical use of the drug/ the general characteristics of the drug approved by the Ministry of Health of the Russian Federation.

important!

The information provided as a response does not replace the advice of a healthcare professional. If your question concerns your health status and/or the prescribed treatment, then you should contact your doctor. Only the attending physician can assess the state of health, decide on the appointment of the drug, the schedule and mode of its administration, as well as the decision to cancel the drug.

Upon request, healthcare professionals can receive expanded scientific and medical information about the company's products.

Please note: by clicking the "Send request" button, you confirm your consent to the processing of the personal data specified in the request form. Personal data will be used by Avexima OJSC solely to provide a response to your request and will not be shared with third parties.